Skip to content
中文产业新闻评分66Chinese source

阿替利珠单抗静脉注射与皮下制剂同步获FDA批准，用于dMMR结肠癌术后辅助治疗

阿替丽珠单抗静脉注射与皮下制剂同步获批，dMMR结肠癌术后辅助治疗迎来突破

Original articleChinese edition

No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.